EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Viral Escape from a Candidate HIV-1 Vaccine Targeting Protease Cleavage Sites Is Associated with a Dramatic Fitness Loss in SIVmac239-Infected Cynomolgus Macaques

So-Yon Lim iD, Ma Luo, James B Whitney

Viruses · 17.03.2026 · 18 (3) · 370

DOI: 10.3390/v18030370 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, online erschienen am 17.03.2026. Verfasst von So-Yon Lim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. Hauptthemen laut MEDLINE: Simian Immunodeficiency Virus, AIDS Vaccines, Simian Acquired Immunodeficiency Syndrome, HIV-1. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A novel HIV-1 vaccine candidate under development targeting the highly conserved protease cleavage regions reduced viral acquisition and delayed disease progression in a macaque SIV-challenge model. Breakthrough virus isolated from vaccinees and control animals were sequenced in the regions surrounding the SIV protease cleavages. We identified unique viral mutations that were associated with alterations in viral load and maintenance of CD4+ T cell counts in vaccinees. To evaluate whether the vaccine-elicited mutations were detrimental to virus fitness, we produced 11 mutant constructs and transfection-derived viral stocks harboring mutations in both PCS2 (in CA/p2) and PCS12 (in Nef) that had emerged at high frequency during breakthrough viremia. Virus preparations harboring mutations displayed impaired proteolytic Gag processing, reduced viral RNA incorporation and p27-CA content. These mutants were also compromised in their ability to replicate in primary cells and cell lines. Interestingly, we observed only partial compensation of these PCS2 defects by downstream mutation at PCS12. In sum, we demonstrate that vaccine-elicited immunity directed to viral protease cleavage regions impair viral escape, and breakthrough virus cannot easily restore replicative fitness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Simian Immunodeficiency VirusAIDS VaccinesSimian Acquired Immunodeficiency SyndromeHIV-1Genetic FitnessAnimalsViral LoadVirus ReplicationMacaca fascicularisMutationBreakthrough Infections

Stichwörter der Autor:innen

HIV vaccineSIVmac251rhesus modelviral fitness

Substanzen

AIDS Vaccines

Autor:innen und Institutionen

  • Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.

ORCID-Profile: So-Yon Lim

Förderung

  • NIH

Zitieren

APA

Lim, S. Y., Luo, M., & Whitney, J. B. (2026). Viral Escape from a Candidate HIV-1 Vaccine Targeting Protease Cleavage Sites Is Associated with a Dramatic Fitness Loss in SIVmac239-Infected Cynomolgus Macaques. Viruses, 18(3), 370. https://doi.org/10.3390/v18030370

Vancouver

Lim SY, Luo M, Whitney JB. Viral Escape from a Candidate HIV-1 Vaccine Targeting Protease Cleavage Sites Is Associated with a Dramatic Fitness Loss in SIVmac239-Infected Cynomolgus Macaques. Viruses. 2026;18(3):370. doi:10.3390/v18030370

BibTeX
@article{Lim2026,
  author = {Lim, So-Yon and Luo, Ma and Whitney, James B},
  title = {Viral Escape from a Candidate HIV-1 Vaccine Targeting Protease Cleavage Sites Is Associated with a Dramatic Fitness Loss in SIVmac239-Infected Cynomolgus Macaques},
  journal = {Viruses},
  year = {2026},
  volume = {18},
  number = {3},
  pages = {370},
  doi = {10.3390/v18030370}
}
Kostenlos starten →